Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS
· Delayed Price · Currency is USD
1.400
0.00 (0.00%)
At close: Jan 20, 2026
Raphael Pharmaceutical Market Cap
Raphael Pharmaceutical has a market cap or net worth of $28.25 million as of April 29, 2026.
Market Cap
28.25M
Enterprise Value
28.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.40
Market Cap Chart
Since January 5, 2023, Raphael Pharmaceutical's market cap has decreased from 34.37M to 28.25M, a decrease of -17.82%. That is a compound annual growth rate of -6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 28.25M | 2.80% |
| Dec 24, 2025 | 27.48M | -20.06% |
| Jan 5, 2023 | 34.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kaya Holdings | 28.14M |
| High Sierra Technologies | 28.98M |
| MariMed | 31.51M |
| Healthy Extracts | 21.11M |
| Radnostix | 40.78M |
| Earth Science Tech | 42.24M |
| Bio Essence | 17.10M |
| Sofgen Pharma | 58.41M |